Industry Organised Sessions

Saturday 13 May 2017

16:00 – 17:30 h, Mozart Hall

Hypophosphatasia in adults with paediatric onset of disease: unmet needs, challenges and opportunities
Co-Chairs: Professor Franz Jakob , University of Würzburg, Würzburg, Germany and Professor Florian Barvencik, University Clinic Hamburg-Eppendorf, Hamburg, Germany

16:00 – 16:05    Welcome and introduction
Professor Franz Jakob,     University of Würzburg, Würzburg, Germany

16:05 – 16:25    Case study: Investigation of bone pain in an adult patient with paediatric-onset hypophosphatasia (HPP)
Professor Florian Barvencik, University Clinic Hamburg-Eppendorf, Hamburg, Germany

16:25 – 16:40    The physiotherapist perspective on assessing physical function in adults with paediatric-onset HPP
Chantal Verhille, University of Leuven, Leuven, Belgium

16:40 – 17:05    Case study: Managing and treating adult patients with paediatric-onset HPP
Professor Francesco Conti, Sapienza University, Rome Italy

17:05 – 17:25    Panel discussion and Q & A session
All faculty

17:25 – 17:30    Conclusions
Professor Franz Jakob,     University of Würzburg, Würzburg, Germany


Sunday 14 May 2017

12:30 – 14:00, Europe Hall

Optimising the management of osteoporosis in elderly patients
Chair: Heinrich Resch, Austria

12:30 – 12:40    Welcome and introduction
Heinrich Resch, Austria

12:40 – 13:10    How can we best identify elderly patients with increased risk of fracture?
Kristina Åkesson, Sweden

13:10 – 13:40     Long-term management of elderly patients with post-menopausal osteoporosis
Socrates Papapoulos, The Netherlands

13:40 – 14:00    Discussion – reflecting back
All faculty


Monday 15 May 2017

12:45 – 14:15, Mozart Hall

Fragility factures: Using science to break the silence

12:45 – 12:55    Welcome
Mattias Lorentzon, Sweden and Lorenz Hofbauer, Germany

12:55 – 13:30    Part 1. Why the first fracture is seldom the last – bone biology, pathology and fracture risk
Kassim Javaid, UK
Moderated by: Mattias Lorentzon and Lorenz Hofbauer

13:30 – 14:10    Part 2. From rare skeletal disorders to novel treatments – a molecular approach
Ken Pooloe, UK
Moderated by: Mattias Lorentzon and Lorenz Hofbauer

14:10 – 14:15    Summary and close
Mattias Lorentzon and Lorenz Hofbauer